SCHEMBL30465415

SCHEMBL30465415

COc1cc2c(Oc3cc(F)c(-c4nccc(OC)c4C(N)=O)cc3F)ccnc2cc1OCCCN1CCOCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 3/20 0.67
FLT3 P36888 4/20 0.60
MET P08581 15/20 0.59
KDR P35968 3/20 0.59
INSR P06213 2/20 0.59
PLK4 O00444 1/20 0.59
STK25 O00506 1/20 0.59
CIT O14578 1/20 0.59
AURKA O14965 1/20 0.59
CHUK O15111 1/20 0.59
MUSK O15146 1/20 0.59
EPHB6 O15197 1/20 0.59
MAPK13 O15264 1/20 0.59
MAP3K13 O43283 1/20 0.59
DAPK3 O43293 1/20 0.59
MAP3K7 O43318 1/20 0.59
RIPK2 O43353 1/20 0.59
JAK2 O60674 1/20 0.59
ROCK2 O75116 1/20 0.59
PAK3 O75914 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25233374 0.94 AXL (0.66) AXLFLT3METKDRINSR
SCHEMBL25278954 0.92 AXL (0.62) AXLFLT3METKDRINSR
SCHEMBL1555923 0.85 AXL (0.78) AXLFLT3METKDRINSR
SCHEMBL14742820 0.83 AXL (0.81) AXLFLT3METKDRINSR
SCHEMBL30465532 0.83 AXL (0.81) AXLFLT3METKDRINSR
SCHEMBL1591146 0.81 AXL (0.71) AXLFLT3METKDRINSR
SCHEMBL6431273 0.81 AXL (0.73) AXLFLT3METKDRINSR
SCHEMBL25719174 0.81 AXL (0.73) AXLFLT3METKDRINSR
SCHEMBL30465529 0.80 AXL (0.51) AXLFLT3MET
SCHEMBL14289180 0.80 AXL (1.00) AXLFLT3METKDRINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448510-A1 INHIBITORS OF MET KINASE Kinnate Biopharma Inc. (US) 2024-10-23 EP disclosed
WO-2023114809-A1 INHIBITORS OF MET KINASE KINNATE BIOPHARMA INC. (US) 2023-06-22 WO disclosed